China

China bans GSK from drug procurement activities through April 2024
China bans GSK from drug procurement activities through April 2024
Endpoints
China
GSK
Flag link:
Bayer, Hua Medicine snag first-in-class nod in China for Roche castoff diabetes drug
Bayer, Hua Medicine snag first-in-class nod in China for Roche castoff diabetes drug
Fierce Pharma
Hua Medicine
Bayer
Roche
China
diabetes
dorzagliatin
Flag link:
Astellas reports Phase III data of fezolinetant for menopause-linked VMS
Astellas reports Phase III data of fezolinetant for menopause-linked VMS
Clinical Trials Arena
Astellas
clinical trials
menopause
China
fezolinetant
vasomotor symptoms
hot flashes
Flag link:
Targeting Novo Nordisk in China's obesity market with a unique proposition, LeaderMed eyes US IPO
Targeting Novo Nordisk in China's obesity market with a unique proposition, LeaderMed eyes US IPO
Fierce Biotech
Novo Nordisk
obesity
China
IPOs
Flag link:
Sorrento to begin Phase I trial of oral Covid-19 treatment
Sorrento to begin Phase I trial of oral Covid-19 treatment
Clinical Trials Arena
Sorrento Therapeutics
COVID-19
China
STI-1588
Flag link:
China's Jemincare nabs $650M biobucks pact with Roche's Genentech for prostate cancer hopeful
China's Jemincare nabs $650M biobucks pact with Roche's Genentech for prostate cancer hopeful
Fierce Biotech
Roche
Genentech
China
Jemincare
biobucks
prostate cancer
Flag link:
Looking east, Sanofi pens 'pioneering' cancer drug partnership with China's Innovent
Looking east, Sanofi pens 'pioneering' cancer drug partnership with China's Innovent
Fierce Biotech
Sanofi
China
oncology
cancer
Innovent
Flag link:
Merck's ADC hunt continues with second deal for China biotech Kelun
Merck's ADC hunt continues with second deal for China biotech Kelun
Endpoints
Merck
antibody-drug conjugate
solid tumors
China
Kelun Biotech
Flag link:
Low-profile startup stakes its claim to Sanofi's siRNA platform in wake of setbacks
Low-profile startup stakes its claim to Sanofi's siRNA platform in wake of setbacks
Endpoints
siRNA
China
Sanofi
Rona Therapeutics
Flag link:
AstraZeneca, Pfizer, Novartis and more lose out in China's latest round of drug price cuts
AstraZeneca, Pfizer, Novartis and more lose out in China's latest round of drug price cuts
Fierce Pharma
China
drug pricing
price cuts
AstraZeneca
Pfizer
Novartis
generics
Flag link:
VC dollars keep rolling in as Qiming ties a ribbon on $2.5B Fund VIII
VC dollars keep rolling in as Qiming ties a ribbon on $2.5B Fund VIII
Endpoints
venture capital
Qiming Ventures
funding
China
Flag link:
Biopharma Investment in China is Thriving Amid U.S. Downturn
Biopharma Investment in China is Thriving Amid U.S. Downturn
BioSpace
China
biotech
WuXi Biologics
Boehringer Ingelheim
Siemens Healthineers
AstraZeneca
Flag link:
Amgen takes next step with its China ambitions, out-licensing drugs to Fosun Pharma
Amgen takes next step with its China ambitions, out-licensing drugs to Fosun Pharma
Endpoints
Amgen
China
Fosun Pharmaceutical
Flag link:
AstraZeneca continues to build out its presence in China with new COPD drug manufacturing site
AstraZeneca continues to build out its presence in China with new COPD drug manufacturing site
Endpoints
AstraZeneca
China
COPD
drug manufacturing
Flag link:
Merck snaps up cancer drug from China’s Kelun in $1.4bn deal
Merck snaps up cancer drug from China’s Kelun in $1.4bn deal
Pharmaforum
Merck
immuno-oncology
China
Sichuan Kelun Pharmaceutical
Flag link:
Merck KGaA warns of volatile 2022 thanks to war in Ukraine and fresh COVID lockdowns in China
Merck KGaA warns of volatile 2022 thanks to war in Ukraine and fresh COVID lockdowns in China
Fierce Pharma
Merck KGaA
Ukraine
Russia
China
COVID-19
Flag link:
GlaxoSmithKline trade secret theft case strikes down Swiss scientist, its 5th target, in conviction
GlaxoSmithKline trade secret theft case strikes down Swiss scientist, its 5th target, in conviction
Fierce Pharma
GSK
trade secrets
DOJ
China
Flag link:
Quiet CDMO makes noise, throwing down $500M for manufacturing campus and moving forward with China operations
Quiet CDMO makes noise, throwing down $500M for manufacturing campus and moving forward with China operations
Endpoints
VectorBuilder
CDMOs
China
chicago
drug manufacturing
Flag link:
Biden likely to sign a bill that would crack down on China's chokehold on the antibiotic supply
Biden likely to sign a bill that would crack down on China's chokehold on the antibiotic supply
Endpoints
Senate
legislation
China
antibiotics
Joe Biden
Flag link:
Another strike for biotech: China
Another strike for biotech: China
EP Vantage
biotech
China
foreign inspections
Flag link:

Pages